l o a d i n g
:::

網路掛號

字級:

:::
首頁 > 團隊介紹 > 陳肇隆 醫生資料

陳肇隆

醫師

一般外科、肝臟移植、肝膽外科、消化系外科、肝膽腫瘤、黃疸、吐血

醫生資料

現職

  • 高雄長庚紀念醫院名譽院長
  • 長庚大學外科教授

經歷

  • 長庚決策委員會副主任委員
  • 高雄長庚紀念醫院院長
  • 高雄長庚紀念醫院副院長
  • 高雄長庚紀念醫院外科部主任
  • 長庚大學外科教授
  • 基隆長庚紀念醫院外科主任
  • 台北林口長庚紀念醫院外科主治醫師

學歷

  • 高雄醫學大學醫學院醫學系

語言

  • 國語,英語,閩南語

教職

  • 教授

學會與認證

  • 台灣外科醫學會外科專科醫師
  • 台灣消化系外科醫學會專科醫師
  • 台灣小兒外科醫學會專科醫師
  • 新疆醫科大學客座教授
  • 新加坡衛生部顧問
  • 正修科技大學名譽博士
  • 新加坡樟宜醫院傑出客座顧問
  • 新加坡樟宜醫院客座專家
  • 中國第四軍醫大學客座教授
  • 重慶醫科大學客座教授
  • 北京大學客座教授
  • 北京協和醫科大學名譽教授
  • 上海交通大學客座教授
  • 中國工程院院士
  • 浙江大學醫學院客座教授
  • 四川大學華西臨床醫學院客座教授
  • 中國人民解放軍總醫院客座教授
  • 天津醫科大學三中心臨床學院客座教授
  • 廣州中醫藥大學客座教授
  • 北京大學客座教授
  • 菲律賓外科學院榮譽院士
  • 中國醫學科學院北京協和醫院客座教授
  • 南開大學天津第一中心醫院客座教授
  • 中國第三軍醫大學客座教授
  • 首都醫科大學北京友誼醫院客座教授
  • 中國醫科大學名譽教授
  • 行政院傑出科學與技術人才獎
  • 美國邁阿密大學客座教授
  • 第一屆高雄醫學院傑出校友
  • 長庚紀念醫院傑出醫務人員

論文及期刊發表

  • Taiwan AFP-child-TNM (TACT) staging system for hepatoma: A new system with adequate grouping and reasonable weight of predictors.
  • Segmental regeneration in right-lobe liver grafts in adult living donor liver transplant.
  • The impact of intrapulmonary shunting after liver transplantation in pediatric patients.
  • Connectivity of default-mode network is associated with cerebral edema in hepatic encephalopathy.
  • Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T 1H-magnetic resonance spectroscopy.
  • Relationship between postoperative lung atelectasis and position of the endotracheal tube in pediatric living-donor liver transplantation.
  • The 4-week serum creatinine level predicts long-term renal dysfunction after adult living donor liver transplantation.
  • Predictive factors for persistent splenomegaly and hypersplenism after adult living donor liver transplantation.
  • Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation.
  • Intra-operative management of low portal vein flow in pediatric living donor liver transplantation.
  • Using ileocolic artery for successful graft salvage in a recipient with hepatic artery thrombosis after living donor liver transplantation: case report.
  • Hemodynamics of portal venous stenosis before and after treatment in pediatric liver transplantation: evaluation with Doppler ultrasound.
  • Biliary complications and management in pediatric living donor liver transplantation for underlying biliary atresia.
  • Hemodynamic changes during the anhepatic phase in pediatric patient with biliary atresia versus glycogen storage disease undergoing living donor liver transplantation.
  • Hepatocellular carcinoma downstaging in liver transplantation.
  • Effect of university of wisconsin and histidine-tryptophan-ketoglutarate preservation solutions on blood potassium levels of patients undergoing living-donor liver transplantation.
  • Pain management of living liver donors with morphine with or without ketorolac.
  • Magnetic resonance cholangiography in living donor liver transplantation: comparison of preenhanced and post-gadolinium-enhanced methods.
  • Immunological and Regenerative Aspects of Hepatic Mast Cells in Liver Allograft Rejection and Tolerance.
  • Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in a Swine Hemi-Facial Allotransplantation Model.
  • Regeneration and Outcome of Dual Grafts in Living Donor Liver Transplantation.
  • The effect of exogenous histone H1 on rat adipose-derived stem cell proliferation, migration, and osteogenic differentiation in vitro.
  • All-in-one sleeve patch graft venoplasty for multiple hepatic vein reconstruction in living donor liver transplantation.
  • Intraoperative portal vein stent placement in pediatric Living Donor Liver Transplantation.
  • Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
  • Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation.
  • Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma Underwent Curative Resection.
  • Significant volume reduction and shape abnormalities of the basal ganglia in cases of chronic liver cirrhosis.